AstraZeneca vaccine reportedly effective against Brazilian Covid-19 strain
8th Mar 2021 11:48
(Sharecast News) - The Covid-19 vaccine developed by AstraZeneca and the University of Oxford does protect against the new strain of the virus detected in the South American, the results of a study conducted by Oxford researchers showed.
Read moreEU not in talks to buy Russian Covid-19 vaccine
4th Mar 2021 12:35
(Sharecast News) - The European Commission said on Thursday that there were no ongoing negotiations about buying Russia's Sputnik V coronavirus vaccine.
Read moreWednesday broker round-up
3rd Mar 2021 13:05
(Sharecast News) - Croda International: Berenberg reiterates buy with a target price of 7,400p.
Read moreUS court rules in favour of AstraZeneca over Symbicort
3rd Mar 2021 07:40
(Sharecast News) - A US court has ruled in favour of AstraZeneca in patent litigation concerning asthma treatment Symbicort, the Anglo-Swedish drugs firm said on Wednesday.
Read moreEU considers emergency approvals for Covid-19 vaccines
2nd Mar 2021 15:42
(Sharecast News) - The European Commission said on Tuesday it was considering emergency approvals for Covid-19 vaccines.
Read moreTuesday broker round-up
2nd Mar 2021 14:00
(Sharecast News) - Sumo Group: Canaccord upgrades to buy with a target price of 340p.
Read moreFDA to review AstraZeneca and FibroGen's Roxadustat
2nd Mar 2021 08:54
(Sharecast News) - Pharmaceutical giant AstraZeneca said on Tuesday that the Food and Drug Administration will convene a meeting of its Cardiovascular and Renal Drugs Advisory Committee to review a new US drug application for Roxadustat.
Read moreAstraZeneca sells stake in Moderna for $1.2bn
1st Mar 2021 08:41
(Sharecast News) - AstraZeneca has cashed in on its bet on Moderna, it was revealed on Monday, as the latter's share price rocketed on the success of its Covid-19 vaccine.
Read moreAstraZeneca and Pfizer vaccines cut hospitalisations significantly
22nd Feb 2021 12:32
(Sharecast News) - The UK's vaccination programme is having "spectacular" success in reducing the number of serious illnesses, the results of a study showed.
Read moreAstraZeneca withdraws Imfinzi US indication for advanced bladder cancer
22nd Feb 2021 08:04
(Sharecast News) - Drugmaker AstraZeneca announced the voluntary withdrawal of its Imfinzi indication in the US for previously treated adult patients with locally advanced or metastatic bladder cancer on Monday.
Read moreJohnson to push G-7 on measures to speed development of new vaccines
19th Feb 2021 13:57
(Sharecast News) - The Prime Minister will push his G7 country counterparts on Friday to cut the development time needed for vaccines against new Covid-19 strains from 300 days to 100.
Read moreAstraZeneca's breast cancer drug moves to early primary analysis
17th Feb 2021 07:52
(Sharecast News) - AstraZeneca said the phase 3 trial for breast cancer drug Lynparza would move to early primary analysis and reporting following a recommendation from the Independent Data Monitoring Committee (IDMC).
Read moreUK officials concerned by continued mutations in Covid-19 strains
11th Feb 2021 12:40
(Sharecast News) - A top UK health official expressed concern about the likely spread of the so-called UK variant worldwide and the fact that it was continuing to mutate.
Read moreAfrica to continue with AstraZeneca vaccination program
11th Feb 2021 10:51
(Sharecast News) - The African Union's disease control body said on Thursday that it would continue using the AstraZeneca Covid19 vaccine, after trial data showed it had greatly reduced efficacy against the coronavirus variant dominant in South Africa.
Read moreThursday preview: US jobless claims, AstraZeneca in the spotlight
10th Feb 2021 18:52
(Sharecast News) - The economic calendar on Thursday will be exceedingly light with a reading on weekly US unemployment claims the only event that might easily move markets.
Read more